Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shereen Ezzat

Showing results (101-110 of 249) with videos related to

Pageof 25
Sort By:
Virchows Archiv : an International Journal of Pathology|August 6, 2013
Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau diseaseHasan Gucer, Eva Szentgyorgyi, Shereen Ezzat, et al.
Cancers|June 19, 2019
Treatment Options for Pancreatic Neuroendocrine TumorsAmit Akirov, Vincent Larouche, Sameerah Alshehri, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2012
CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxiaKatie Dorman, Zhongyi Shen, Caimei Yang, et al.
Leukemia Research|January 8, 2008
Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cellsXinliang Mao, Xuegong Zhu, Rose Hurren, et al.
Endocrine-Related Cancer|March 6, 2009
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancerSonia Cheng, Wei Liu, Moises Mercado, et al.
Frontiers in Endocrinology|August 10, 2019
A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for HypothyroidismAmit Akirov, Rouhi Fazelzad, Shereen Ezzat, et al.
Molecular Endocrinology (Baltimore, Md.)|July 29, 2006
Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cellsShereen Ezzat, Xuegong Zhu, Siobhan Loeper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
A high-throughput proteomic approach provides distinct signatures for thyroid cancer behaviorSonia Cheng, Stefano Serra, Moises Mercado, et al.
Cancer Research|February 21, 2012
FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progressionMiao Guo, Wei Liu, Stefano Serra, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 17, 2009
A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegalyShereen Ezzat, Rania Gaspo, Omar Serri, et al.
Pageof 25

Showing results (101-110 of 249) with videos related to

Sort By:
Pageof 25
Virchows Archiv : an International Journal of Pathology|August 6, 2013
Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel-Lindau diseaseHasan Gucer, Eva Szentgyorgyi, Shereen Ezzat, et al.
Cancers|June 19, 2019
Treatment Options for Pancreatic Neuroendocrine TumorsAmit Akirov, Vincent Larouche, Sameerah Alshehri, et al.
Molecular Endocrinology (Baltimore, Md.)|February 4, 2012
CtBP1 interacts with Ikaros and modulates pituitary tumor cell survival and response to hypoxiaKatie Dorman, Zhongyi Shen, Caimei Yang, et al.
Leukemia Research|January 8, 2008
Dexamethasone increases ubiquitin transcription through an SP-1 dependent mechanism in multiple myeloma cellsXinliang Mao, Xuegong Zhu, Rose Hurren, et al.
Endocrine-Related Cancer|March 6, 2009
Expression of the melanoma-associated antigen is associated with progression of human thyroid cancerSonia Cheng, Wei Liu, Moises Mercado, et al.
Frontiers in Endocrinology|August 10, 2019
A Systematic Review and Meta-Analysis of Patient Preferences for Combination Thyroid Hormone Treatment for HypothyroidismAmit Akirov, Rouhi Fazelzad, Shereen Ezzat, et al.
Molecular Endocrinology (Baltimore, Md.)|July 29, 2006
Tumor-derived Ikaros 6 acetylates the Bcl-XL promoter to up-regulate a survival signal in pituitary cellsShereen Ezzat, Xuegong Zhu, Siobhan Loeper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2011
A high-throughput proteomic approach provides distinct signatures for thyroid cancer behaviorSonia Cheng, Stefano Serra, Moises Mercado, et al.
Cancer Research|February 21, 2012
FGFR2 isoforms support epithelial-stromal interactions in thyroid cancer progressionMiao Guo, Wei Liu, Stefano Serra, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|December 17, 2009
A Canadian multi-centre, open-label long-term study of Pegvisomant treatment in refractory acromegalyShereen Ezzat, Rania Gaspo, Omar Serri, et al.
Pageof 25